Surgery Partners, Inc. (SGRY) stock
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/3011% above fair value
$26.96+0.11 (+0.41%)
Close on Nov 18, 2026Market cap $3.53BP/E –Yield –
Surgery Partners operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Surgery Partners's operating income for the twelve months ending Jun 30, 2026 was $383.80M, up 6.1% year over year. For fiscal 2025 it was $389.50M, up 11.7% from the year before. Over ten years it grew 22.6% a year on average. The highest annual figure on record is $389.50M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $389.50M | +11.7% |
| FY2024 | Dec 31, 2024 | $348.80M | +6.3% |
| FY2023 | Dec 31, 2023 | $328.00M | -5.0% |
| FY2022 | Dec 31, 2022 | $345.20M | +14.2% |
| FY2021 | Dec 31, 2021 | $302.20M | +65.1% |
| FY2020 | Dec 31, 2020 | $183.00M | -22.4% |
| FY2019 | Dec 31, 2019 | $235.90M | +203.2% |
| FY2018 | Dec 31, 2018 | $77.80M | -60.4% |
| FY2016 | Dec 31, 2016 | $196.48M | +35.7% |
| FY2015 | Dec 31, 2015 | $144.75M | +184.9% |
| FY2014 | Dec 31, 2014 | $50.81M | -12.7% |
| FY2013 | Dec 31, 2013 | $58.23M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $102.10M | -8.6% |
| Q1 FY2026 | Mar 31, 2026 | $65.80M | +6.3% |
| Q4 FY2025 | Dec 31, 2025 | $110.20M | -13.3% |
| Q3 FY2025 | Sep 30, 2025 | $105.70M | +73.6% |
| Q2 FY2025 | Jun 30, 2025 | $111.70M | +31.7% |
| Q1 FY2025 | Mar 31, 2025 | $61.90M | -18.6% |
| Q4 FY2024 | Dec 31, 2024 | $127.10M | +25.3% |
| Q3 FY2024 | Sep 30, 2024 | $60.90M | -26.3% |
| Q2 FY2024 | Jun 30, 2024 | $84.80M | -13.1% |
| Q1 FY2024 | Mar 31, 2024 | $76.00M | +63.8% |
| Q4 FY2023 | Dec 31, 2023 | $101.40M | +7.6% |
| Q3 FY2023 | Sep 30, 2023 | $82.60M | +11.5% |
| Q2 FY2023 | Jun 30, 2023 | $97.60M | +27.6% |
| Q1 FY2023 | Mar 31, 2023 | $46.40M | -53.8% |
| Q4 FY2022 | Dec 31, 2022 | $94.20M | -17.9% |
| Q3 FY2022 | Sep 30, 2022 | $74.10M | +16.5% |
| Q2 FY2022 | Jun 30, 2022 | $76.50M | +28.6% |
| Q1 FY2022 | Mar 31, 2022 | $100.40M | +56.1% |
| Q4 FY2021 | Dec 31, 2021 | $114.80M | +19.2% |
| Q3 FY2021 | Sep 30, 2021 | $63.60M | +243.8% |
| Q2 FY2021 | Jun 30, 2021 | $59.50M | +33.1% |
| Q1 FY2021 | Mar 31, 2021 | $64.30M | +173.6% |
| Q4 FY2020 | Dec 31, 2020 | $96.30M | +34.1% |
| Q3 FY2020 | Sep 30, 2020 | $18.50M | -68.6% |
| Q2 FY2020 | Jun 30, 2020 | $44.70M | -19.5% |
| Q1 FY2020 | Mar 31, 2020 | $23.50M | -52.6% |
| Q4 FY2019 | Dec 31, 2019 | $71.80M | – |
| Q3 FY2019 | Sep 30, 2019 | $59.00M | +31.1% |
| Q2 FY2019 | Jun 30, 2019 | $55.50M | +27.6% |
| Q1 FY2019 | Mar 31, 2019 | $49.60M | +20.4% |
| Q4 FY2018 | Dec 31, 2018 | -$51.90M | -237.5% |
| Q3 FY2018 | Sep 30, 2018 | $45.00M | +7.9% |
| Q2 FY2018 | Jun 30, 2018 | $43.50M | -36.4% |
| Q1 FY2018 | Mar 31, 2018 | $41.20M | -3.8% |
| Q2 FY2017 | Jun 30, 2017 | $37.74M | – |
| Q1 FY2017 | Mar 31, 2017 | $41.72M | – |
| Q4 FY2016 | Dec 31, 2016 | $68.41M | – |
| Q3 FY2016 | Sep 30, 2016 | $42.85M | – |
See a number that looks wrong?